Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nice Ltd ADR (NQ: NICE )

171.27 -5.46 (-3.09%)
Streaming Delayed Price Updated: 12:58 PM EDT, Aug 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Nice Ltd ADR

< Previous 1 2 3 4 5 Next >
NICE Stock Gains On Q3 Beat, Raised FY21 Outlook
NICE Ltd (NASDAQ: NICE) reported third-quarter FY21 non-GAAP revenue growth of 20% year on year to $494.4 million, beating the consensus of $465.8 million. ... 
Via Benzinga
Earnings Scheduled For November 11, 2021
Companies Reporting Before The Bell • NICE (NASDAQ:NICE) is likely to report quarterly earnings at $1.58 per share on revenue of $465.75 million. • Reshape... 
Via Benzinga
Okta Stock Scores Rising Relative Strength Upgrade
Okta shows rising price performance, earning an upgrade to its IBD Relative Strength Rating 
Via Investor's Business Daily
10 Biggest Price Target Changes For Thursday
Telsey Advisory Group lifted the price target on Lululemon Athletica Inc. (NASDAQ: LULU) from $460 to $485. Lululemon shares surged 13.9% to $433.58 in pre-market trading.... 
Via Benzinga
NICE Ltd (NICE) Q2 2021 Earnings Call Transcript
NICE earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Recap: NICE Q2 Earnings
Shares of NICE (NASDAQ:NICE) fell 1.3% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 14.60% year over year to... 
Via Benzinga
Stocks That Hit 52-Week Highs On Wednesday
Before 10 a.m. ET on Wednesday, 124 companies hit new 52-week highs. Facts of Interest: The largest company by market cap to set a new 52-week high was Alphabet (... 
Via Benzinga
RingCentral slides as Zoom buying Five9 stokes competition concerns
Morgan Stanley says Zoom Video deal for Five9 answers a lot of growth concerns. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2021
Upgrades According to Raymond James, the prior rating for Sunnova Energy International Inc (N... 
Via Benzinga
RBC Upgrades NICE To Outperform From Sector Perform, New Target Price Implies 18% Upside
RBC Capital analyst Rishi Jaluria upgraded NICE Ltd (NASDAQ: NICE) to Outperform rating from Sector Perform. RBC raised the price target to $300 from $266. The... 
Via Benzinga
Philadelphia Picks NICE Inform Elite For New 911 Center
Philadelphia chose NICE Ltd's (NASDAQ: NICE) NICE Inform Elite& to boost emergency communications for its new 911 center slated to open in 2022. NICE's 911-... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 9, 2021
Upgrades According to Deutsche Bank, the prior rating for KLA Corp (NASDAQ:KLAC) was changed from Hold to Buy. KLA earned $3.85 in the third quarter, compared to $2.47 in... 
Via Benzinga
NICE Extends RingCentral Partnership for Selling RingCentral Contact Center Globally
NICE Ltd (NASDAQ: NICE) and RingCentral Inc (NYSE: RNG) have extended their multi-year agreement to market and sell RingCentral Contact Center... 
Via Benzinga
P/E Ratio Insights for NICE
Right now, NICE Inc. (NASDAQ:NICE) share price is at $227.00, after a 1.77% increase. Moreover, over the past month, the stock decreased by 4.48%, but in the past... 
Via Benzinga
Nice Ltd (NICE) Q1 2021 Earnings Call Transcript
NICE earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
NICE: Q1 Earnings Insights
Shares of NICE (NASDAQ:NICE) fell 1.4% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 14.93% year over year to $1.54... 
Via Benzinga
NICE Earnings Preview
NICE (NASDAQ:NICE) announces its next round of earnings this Thursday, May 13. Here is Benzinga's everything-that-matters guide for this Thursday's Q1 earnings announcement. Net... 
Via Benzinga
Earnings Scheduled For May 13, 2021
Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million. •... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.